1. Home
  2. GDOT vs DAWN Comparison

GDOT vs DAWN Comparison

Compare GDOT & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Dot Corporation $0.001 par value

GDOT

Green Dot Corporation $0.001 par value

HOLD

Current Price

$12.98

Market Cap

742.3M

Sector

Finance

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$8.39

Market Cap

624.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDOT
DAWN
Founded
1999
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
742.3M
624.8M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
GDOT
DAWN
Price
$12.98
$8.39
Analyst Decision
Sell
Strong Buy
Analyst Count
2
9
Target Price
$11.00
$26.56
AVG Volume (30 Days)
1.2M
2.6M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,007,128,000.00
$133,672,000.00
Revenue This Year
$22.56
$15.51
Revenue Next Year
$11.63
$49.99
P/E Ratio
N/A
N/A
Revenue Growth
23.16
31.11
52 Week Low
$6.13
$5.64
52 Week High
$15.41
$13.53

Technical Indicators

Market Signals
Indicator
GDOT
DAWN
Relative Strength Index (RSI) 57.08 48.09
Support Level $12.88 $8.13
Resistance Level $13.75 $8.67
Average True Range (ATR) 0.42 0.48
MACD 0.06 -0.07
Stochastic Oscillator 61.31 24.73

Price Performance

Historical Comparison
GDOT
DAWN

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: